908 filings
Page 18 of 46
10-Q
2020 Q3
CPRX
Catalyst Pharmaceuticals Inc
Quarterly report
9 Nov 20
5:09pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
19 Oct 20
Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx
8:04am
8-K
CPRX
Catalyst Pharmaceuticals Inc
6 Oct 20
Other Events
5:26pm
4
Charles B O'Keeffe
30 Sep 20
CATALYST PHARMACEUTICALS / Charles B O'Keeffe ownership change
2:23pm
4
Patrick J Mcenany
30 Sep 20
CATALYST PHARMACEUTICALS / PATRICK J MCENANY ownership change
10:55am
8-K
CPRX
Catalyst Pharmaceuticals Inc
30 Sep 20
Catalyst Pharmaceuticals Announces Ruling on Lawsuit against the FDA and Intent to Appeal
12:00am
8-K
CPRX
Catalyst Pharmaceuticals Inc
11 Sep 20
Departure of Directors or Certain Officers
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
26 Aug 20
Other Events
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
21 Aug 20
Departure of Directors or Certain Officers
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
20 Aug 20
Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce Agreement to Make Firdapse® (amifampridine phosphate) Available to LEMS Patients in Canada
5:15pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
11 Aug 20
Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for “Methods of Administering 3,4
4:46pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
10 Aug 20
Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
5:17pm
10-Q
2020 Q2
CPRX
Catalyst Pharmaceuticals Inc
Quarterly report
10 Aug 20
4:06pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
6 Aug 20
Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives
4:31pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
3 Aug 20
Catalyst Pharmaceuticals Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of Stockholders
5:05pm
DEFA14A
CPRX
Catalyst Pharmaceuticals Inc
3 Aug 20
Additional proxy soliciting materials
5:01pm
EFFECT
CPRX
Catalyst Pharmaceuticals Inc
3 Aug 20
Notice of effectiveness
12:15am
424B3
CPRX
Catalyst Pharmaceuticals Inc
31 Jul 20
Prospectus supplement
5:01pm
CORRESP
CPRX
Catalyst Pharmaceuticals Inc
30 Jul 20
Correspondence with SEC
12:00am
UPLOAD
CPRX
Catalyst Pharmaceuticals Inc
30 Jul 20
Letter from SEC
12:00am